Current price is more than the intrinsic value
Stock has not been able to generate better return on equity than bank FD
Stock doesn't offer attractive dividend returns
Good time to consider, as stock is not in overbought zone
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
PE RatioPE Ratio | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
26.94 | 2.83 | 0.98% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
38.16 | 4.82 | 0.92% |
Bal Pharma Limited is engaged in the manufacture and sale of pharmaceutical products. The Company’s business comprises of Active Pharmaceutical Ingredients (API), Finished Formulations, Ayurvedic, Research and Development.
Customise key metrics, see detailed forecasts, download stock data and more
In last 6 months, promoter holding in the company has increased by 2.43%
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Bal Pharma Limited has informed the Exchange about press release dated 12-Aug-2022 titled Bal Pharma Ltd announces Q1FY23 financial results | Download
Bal Pharma Limited has informed the Exchange about press release dated 12-Aug-2022 titled Bal Pharma Ltd announces Q1FY23 financial results | Download
Bal Pharma Limited has informed the Exchange about Board Meeting held on 11-Aug-2022 to consider financial statements for the period ended June 2022 | Download
Bal Pharma Limited has informed the Exchange about Board Meeting held on 11-Aug-2022 to consider financial statements for the period ended June 2022 | Download
Final • Div/Share: ₹ 1
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Current price is more than the intrinsic value